日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer

胃切除术对胃癌患者发生酒精相关性肝病风险的影响

Moon, Sang Yi; Baek, Yang Hyun; Kang, Dongwoo; Lee, Jungkuk; Kang, Yeo Wool; Son, Minkook; Liu, Hongqun; Lee, Samuel S; Park, Junho

Bioprinting of hepatic tissue model using photocrosslinkable dECM-containing composite hydrogel.

利用光交联 dECM 复合水凝胶进行肝组织模型生物打印

Tabatabaei Rezaei Nima, Kumar Hitendra, Liu Hongqun, Rajeev Ashna, Natale Giovanniantonio, Lee Samuel S, Park Simon S, Kim Keekyoung

Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition

恩格列净用于治疗非糖尿病代谢功能障碍相关脂肪肝:一种前景广阔的过渡期治疗药物

El-Kassas, Mohamed; Liu, Hongqun; Lee, Samuel S

Lubiprostone Reduces Fat Content on MRI-PDFF in Patients With MASLD: A 48-Week Randomised Controlled Trial

鲁比前列酮降低MASLD患者的MRI-PDFF脂肪含量:一项为期48周的随机对照试验

El-Kassas, Mohamed; Mostafa, Hala; Abdellatif, Wessam; Shoman, Sohier; Esmat, Gamal; Brahmania, Mayur; Liu, Hongqun; Lee, Samuel S

Apoptosis in Cardiac Conditions Including Cirrhotic Cardiomyopathy

心脏疾病(包括肝硬化性心肌病)中的细胞凋亡

Yu, Fengxue; Ryu, Dae Gon; Yoon, Ki Tae; Liu, Hongqun; Lee, Samuel S

Epidemiology of Chronic Hepatitis C in First Nations Populations in Canadian Prairie Provinces

加拿大草原省份原住民人群中慢性丙型肝炎的流行病学

Dunn, Kate P R; Wardman, Dennis; Trubnikov, Maxim; Sarin, Chris; Wong, Tom; Liu, Hongqun; Lee, Samuel S

Clinical Features and Prognosis of Cervical Esophageal Cancer

颈段食管癌的临床特征和预后

Ryu, Dae-Gon; Kim, Keekyoung; Liu, Hongqun; Lee, Samuel S; Lee, Sangjune Laurence

Appropriate Timing and Interval for Surveillance Colonoscopy after Liver Transplantation Based on a Single-Centre Experience

基于单中心经验的肝移植术后监测性结肠镜检查的合适时间和间隔

Ryu, Dae Gon; Liu, Hongqun; Lee, Samuel S; Yoon, Ki Tae; Brahmania, Mayur

Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?

肝细胞癌免疫检查点抑制剂治疗失败后的二线治疗:酪氨酸激酶抑制剂、再次免疫疗法还是局部区域治疗?

Hwang, Sang Youn; Lee, Sangjune L; Liu, Hongqun; Lee, Samuel S

Reply to: Correspondence on "Cardiomyopathy in cirrhosis: From pathophysiology to clinical care"

回复:关于“肝硬化心肌病:从病理生理学到临床治疗”的来信

Liu, Hongqun; Naser, Jwan A; Lin, Grace; Lee, Samuel S